ArticleEuropean radiology experimental2026
Phase-adaptive automated whole-liver quantification of signal intensity-derived liver indices from gadoxetic acid-enhanced MRI.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesTo develop and validate a phase-adaptive pipeline for automated whole-liver, parenchyma-based quantification of signal intensity-derived liver indices from gadoxetic acid-enhanced MRI without inter-phase co-registration. MATERIALS AND
methodsIn this retrospective, single-center study (2016-2025), 9,013 liver MRI examinations were screened, and 3,112 gadoxetic acid-enhanced MRI examinations were identified. The first examination per patient defined the clinical cohort (1,174 patients; mean age, 59.6 ± 14 years [range, 4-93 years]; 611 men). A phase-adaptive nnU-Net was trained on 403 and tested on 500 dynamic contrast-enhanced MRI sequences for segmentation of liver parenchyma, intrahepatic non-parenchymal structures, and spleen; paraspinal muscle reference regions were obtained using TotalSegmentator. Segmentation accuracy was assessed against manually corrected reference segmentations generated by a semi-automatic annotation workflow with Dice similarity coefficients. Automated arterial enhancement fraction (AEF), relative liver enhancement (RLE), hepatocellular uptake index (HUI), liver-to-spleen ratio (LSR), and liver-to-muscle ratio (LMR) were compared with manual region-of-interest measurements in a radiological validation cohort (50 patients) using intraclass correlation coefficients and Bland-Altman analysis. Liver indices were compared between patients with cirrhotic and non-cirrhotic livers using the Mann-Whitney U-test.
resultsLiver parenchyma segmentation achieved Dice similarity coefficients of 0.998-0.999. Reader-model agreement for the liver indices ranged from 0.936 to 0.977. HUI, LSR, RLE, and LMR were lower in cirrhosis (p < 0.001), whereas AEF did not differ (p = 0.14).
conclusionPhase-adaptive segmentation enables whole-liver quantification of signal intensity-derived liver indices without inter-phase co-registration. The lower hepatobiliary uptake indices in cirrhosis support the plausibility of this approach for scalable quantitative assessment of liver MRI. KEY POINTS: Question Can gadoxetic acid-enhanced liver MRI be quantified automatically across contrast phases without inter-phase co-registration or manual region-of-interest placement in routine clinical imaging? Findings Phase-adaptive segmentation enabled automated whole-liver quantification with liver Dice coefficients of 0.998-0.999 and excellent agreement with manual measurements for five liver indices. Relevance Statement Automated whole-liver quantification from standard gadoxetic acid-enhanced liver MRI provides reproducible, signal-intensity-derived liver indices and reduces dependence on manual region-of-interest measurements in large-scale clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.